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Review—Single Walled Carbon Nanotubes as Optical Sensors for
Biological Applications
Eric M. Hofferber, Joseph A. Stapleton, and Nicole M. Iverson*,z
Department of Biological Systems Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, United States of
America
Since the discovery of the band gap ﬂuorescence from single walled carbon nanotubes (SWNT) many advancements have been
made towards the use of these unique ﬂuorophores as optical biosensors in vitro, ex vivo in vivo. Attention has been given to these
pure carbon structures due to their photostability, tunable properties, and bright near infrared emission that falls in the tissue
transparency window. This review highlights some of the major advancements in the ﬁeld of SWNT biosensors over the last two
decades with a focus given to recent advances in biological applications.
© 2020 The Author(s). Published on behalf of The Electrochemical Society by IOP Publishing Limited. This is an open access
article distributed under the terms of the Creative Commons Attribution 4.0 License (CC BY, http://creativecommons.org/licenses/
by/4.0/), which permits unrestricted reuse of the work in any medium, provided the original work is properly cited. [DOI: 10.1149/
1945-7111/ab64bf]
Manuscript submitted September 19, 2019; revised manuscript received December 6, 2019. Published January 10, 2020. This paper
is part of the JES Focus Issue on Sensor Reviews.

Biosensors are unique devices capable of converting biological
cues into signals for detection and analysis.1 Such devices are
capable of expanding current knowledge of biological pathways by
informing researchers of key analytes that are involved in processes,
core molecular signaling pathways, and deviations from homeostasis
that are consistent with disease states.2 The expansion of knowledge
gained by the use of biosensors could lead to earlier disease
detection and more targeted therapies.2 Since the ﬁrst paper using
the term “biosensor” by Cammann in 1977, a paper that predominantly discussed work performed using enzyme-based detection,3
the ﬁeld of biosensors has come to describe many more types of
sensors, including cell or tissue-based, immuno, DNA, magnetic,
thermal, piezoelectric, and optical sensors.1,4–10 Yet, despite the
variety of biosensors developed over the last four decades, the same
key qualities are consistently found: stability, high speciﬁcity for a
target, biocompatibility, and limited nonspeciﬁc binding.11–16
Of the aforementioned biosensors, optical biosensors have
generated a great deal of interest in recent years due to their high
sensitivity, rapid detection rate, non-invasive nature, and nondestructive method of action.17–19 The previously mentioned characteristics coupled with the ability of optical biosensors to detect a
wide variety of analytes has led to research targeted at expanding
this branch of biosensors over the last two decades.20 Recently, a
push to move optical biosensors into the near infrared (nIR) region
of the electromagnetic spectrum has gained a great deal of
traction.21–25 Many optical biosensors or ﬂuorescent probes require
excitation in the low end of the visible spectrum or even in the
ultraviolet (UV) region, which can limit sensor timeframes due to
photobleaching of organic molecules, and concerns of phototoxicity
arise when UV light is used on biological matter.26–33 UV and
visible light are also obstructed by biological tissues due to
reﬂection, absorption, and scattering of the light by tissue, water, and
blood.34,35 Consequently, tissue penetration depth for visible light
has been estimated at >0.1 cm,17 but as the wavelengths move
toward the nIR spectrum, tissue penetration increases.21–23,25,34,36,37
For the nIR-I (780–900 nm) and nIR-II (900–1700 nm) regions, light
is capable of penetrating tissue at depths of up to 1 cm and 3 cm
respectively.38,39 The increase in tissue penetration depth that is
observed with nIR wavelengths is attributed to off resonance
frequency of the light compared to water, blood, and tissue, which
leads to less absorption and scattering.40
Of the nIR optical biosensors, carbon nanotubes (CNT) have
been studied at length.41–46 Conceptually, a single walled carbon
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nanotube (SWNT) is a sheet of pure graphene that has been rolled
into a tube that is approximately 1 nm in diameter.47 SWNT are
quasi one-dimensional nanowires with typical lengths varying from
10 nm to a few hundred nanometers,47 however the length can be
much longer with some nanotubes measuring over 50 cm.48 The
orientation of the fully sp2-bonded carbon hexagonal rings determines the helicity of the nanotube and is denoted by two integers (n,
m) that are referred to as the chiral indices (as shown in Fig. 1).49–52
When the value of m is zero the nanotube is in a zigzag structure,
when the values of n and m are equal the nanotube is in an armchair
structure, when n and m are different the nanotube is in a chiral
structure.49–51 Zigzag, armchair, and chiral nanotubes act very
differently and are classiﬁed either semiconducting, metallic, or semi
metallic.49–51,53 Nanotubes have a small enough diameter to be
subject to the quantum conﬁnement effect, which states that the
electrons can only exist in discrete energy levels.54 The band gap
between semiconducting SWNT electrons is on the order of 1 eV,
which leads to ﬂuorescence in the nIR-II range (900–1700 nm) with
excitation typically falling in the nIR-I (780–900 nm) range or in the
higher length visible range (>600 nm).24,54–59 The Stoke-shift
between the excitation and emission wavelengths of SWNT leads
to a decreased autoﬂuorescence when used for imaging in biological
samples, which is another positive factor that is driving the
development and use of SWNT as biosensors.24,51,56,60,61
Many papers have been published over the last two decades
moving towards the use of SWNT as in vitro, ex vivo, and in vivo
optical biosensors.62–74 This review examines the major advancements in SWNT biosensing since the discovery of band gap
ﬂuorescence from individual nanotubes in 2002 with a focus on
recent progress and future directions.
Major Advances: 2002–2016
SWNT was originally discovered by Sumio Iijima in 1991,47
however the discovery of the band gap ﬂuorescence that led to the
use of SWNT as optical biosensors did not occur until O’Connell
et al.’s 2002 paper.55 O’Connell et al. was able to suspend individual
nanotubes in aqueous solutions using sodium dodecyl sulfate (SDS)
and poly(vinylpyrrolidone) (PVP) with sheer mixing and tip
sonication to form cylindrical micelles around the tubes. The
aqueous solution of individual nanotubes was found to brightly
ﬂuoresce at distinct wavelengths within the nIR-II range, which
piqued the interest of chemists, biologists, and engineers since the
tissue transparency window falls in the nIR-II ﬂuorescence range.55
The 650–1350 nm range has been termed as the tissue transparency
window because of the lack of light absorbed by blood or water in
these wavelengths (see Fig. 2).23,75
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Figure 1. Single walled carbon nanotube properties change with the change in their carbon bond angles. When m is zero the nanotube is a zigzag structure, when
n and m are equal the nanotube is an armchair structure, and when n and m are different the nanotube is chiral (ﬁgure adapted with permission from 52, © 2012
The Royal Society of Chemistry).

Two years later, in 2004, multiple labs published research that
advanced our understanding and ability to use SWNT.76–78 Lefebvre
et al. fabricated SWNT using chemical vapor deposition which
resulted in a raw mixture of many different nanotube chiralities.79,80
A modiﬁed microscope was able to image individual SWNT in air
and was able to show distinct excitation and emission wavelengths
for different chiralities (see Fig. 2),81 conﬁrming the hypothesis that
various SWNT chiralities have different band gaps and therefore
distinct excitation and emission wavelengths.78 Heller et al. separated SWNT in aqueous solution by length and diameter using gel
electrophoresis, which enabled sample enrichment with a speciﬁc
SWNT chirality to increase the overall quantum yield (QY) of the
sample.77 Finally, Cherukuri et al. made the ﬁrst leap into in vitro
imaging with SWNT using mouse macrophage-like cells.76 As
predicted, the long wavelength emission of the SWNT allowed for

high signal to noise (s/n) ﬂuorescence detection in the living cells,
and the cells were determined to not be adversely affected by the
nanotubes under the experimental conditions.
Three years later, in 2007, there was another big step in the use of
SWNT as optical biosensors when Leeuw et al. performed the ﬁrst
published in vivo imaging experiment with functionalized SWNT.82
Drosophila larva were fed a diet containing dispersed SWNT and the
viability, size, and ﬂuorescence of the ﬂies was monitored during the
drosophila’s life cycle. The drosophila did not have signiﬁcantly
different life spans or overall size measurements due to the addition
of SWNT, and the SWNT was detectable with nIR imaging in the
digestive system of the animals. This research demonstrated the
potential for biocompatibility and ﬂuorescence functionality of
SWNT in vivo for the ﬁrst time. Following Leeuw et al.’s
demonstration of in vivo detection of SWNT, Welsher et al.

Figure 2. (a) Single walled carbon nanotubes (SWNT) ﬂuorescence within the Tissue Transparency Window, the area between where blood and water absorb
light (ﬁgure reprinted with permission from 75, © 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim). (b) Different chiralities of SWNT are excited and
emit light at different wavelengths (ﬁgure reprinted with permission from 81, © 2006 American Chemical Society).

Journal of The Electrochemical Society, 2020 167 037530

Figure 3. (a) Single walled carbon nanotubes (SWNT) wrapped with single stranded DNA can create ﬂuorescent sensors for various analytes.20,73,84 (b) SWNT
sensors located within the liver show the ability to detect inﬂammation by through signal quenching.85 (c) SWNT encapsulated hydrogels placed subcutaneously
in a mouse can detect the nitric oxide that is released by cutting the skin (ﬂuorescence is quenched within 30 min of hydrogel placement, image was taken 5 min
after gel 1 and 30 min after gel 2 placement).85

demonstrated the ability of SWNT to be utilized in live mammals, by
injecting polyethylene glycol (PEG) modiﬁed SWNT made with the
SDS exchange process into mice and imaging the nanotubes
throughout the animal.68 The relative QY of the PEG-SWNT was
higher than previously employed SWNT due to the decreased
sonication requirements for nanotube dispersion with the exchange
method. Researchers found that PEG-SWNT localized to tumors
when injected into tumor laden mice, developing a method for high
resolution imaging of tumor vasculature.
Cognet et al. advanced the ﬁeld of SWNT sensors by showing a
stepwise quenching of nanotube ﬂuorescence in response to low
levels of acid in 2007.83 By imaging individual nanotubes’ interactions with acid, Cognet et al. demonstrated single molecule detection
by SWNT. A paradigm shift in SWNT sensors occurred in 2009
when Heller et al. showed the potential for SWNT wrapped with
ssDNA to be a multimodal detector by showing simultaneous
detection of four pathways using principal component analysis
(PCA) (see Fig. 3).20 Two chiralities of SWNT (6, 5 and 7, 5),
when wrapped with ss(GT)15, underwent a shift in either wavelength
or intensity following exposure to four different analytes. Through
the use of wavelengths and intensities gathered from both chiralities
PCA was able to detect the presence of multiple analytes at once.
In 2013 SWNT were used as biosensors in live animals for the ﬁrst
time when Iverson et al. demonstrated two methods for in vivo sensor
delivery, intravenous and subcutaneous (Fig. 3).85 Both sensor
delivery methods were performed with ssDNA wrapped SWNT that
were shown to retain their speciﬁcity and functionality in vivo.
Major Advances: 2017–2019
Many advances have been made in the ﬁeld of carbon nanotube
biosensors in the past three years with regards to sensor design and
in vitro, ex vivo and in vivo applications. The next sections highlight
major advances in each application from the last three years.
Sensor development.—The library of available SWNT based
optical biosensors is rapidly expanding each year as scientists are
demonstrating high sensitivity and selectivity to biologically active
markers and analytes. This section highlights the sensors developed
in the past three years.
Catecholamine neurotransmitters, such as dopamine and norepinephrine, have been at the center of SWNT sensor development due
to the difﬁcult nature of in situ detection and quantiﬁcation of
analytes in neural networks. Beyene et al. sought to create a more
targeted approach to sensor design by testing ssDNA interaction
with the neurotransmitters under various conditions to induce an
“ultra large” ﬂuorescence modulation for eventual in vivo

applications.86 The developed (GT)6-SWNT sensor was found to
show a 3500% ﬂuorescence increase in response to the added
neurotransmitters.86 In a study by Mann et al. the issue of discerning
dopamine from norepinephrine was addressed by the fabrication and
testing of multiple neurotransmitter SWNT-based sensors to determine which was capable of distinguishing one catecholamine from
another.84 A30 and (GT)10-SWNT were found to have more
sensitivity to dopamine vs other catecholamine neurotransmitters.84
These increases in ﬂuorescence response and improvement in
speciﬁcity of SWNT-sensors are both key steps towards the goal of
in vivo detection and quantiﬁcation of neurotransmitters.
Expansion of the SWNT senor library has resulted in different
detection methods for target analytes other than the direct interaction
of an analyte with SWNT, which leads to a change in the dielectric
environment, causing shift in emission wavelength or intensity.
Harvey et al. was able to show controlled solvatochromic shifting
of nanotube ﬂuorescence in response to alkylating agents commonly
used as chemotherapy drugs (see Fig. 4).87 The alkylating agents
covalently bind to the nanotube’s DNA wrapping, causing a conformational change in the DNA that exposes more of the SWNT to the
surrounding environment.87 The exposed SWNT was shown to either
red or blue shift depending on the medium that was employed.87
Detection of larger, bioactive proteins has also been an area of interest
for SWNT sensing, Lee et al. used aptamer-SWNT and aptameranchor-SWNT complexes for insulin sensing.88 The SWNT was
functionalized using aptamers that underwent conformational changes
in response to insulin, resulting in a change to the nanotube’s
dielectric environment.88 In a similar vein, Zubkovs et al. designed
a new sensor platform to detect glucose that did not rely on the
addition of exogenous mediators, which limits utility and reversibility
of the sensors, as was previously done.89 Zubkovs et al.’s platform
uses enzymatic pocket doping with a glucose oxidase (GOx) wrapping
to create a glucose sensor that required no mediator and achieves
reversibility of ﬂuorescence response.89 Oxygenated p-doped sites on
the nanotube were shown to decrease nanotube emission while
addition of glucose caused oxidation to occur in the GOx wrapping,
resulting in n-doping and an overall increase in nanotube emission.89
Finally, Dong et al. was able to create a lab-on-a-chip-type sensing
platform using SWNT sensors conjugated to a microarray for
detection and quantiﬁcation of antibodies.90 A SWNT/chitosan ink
was deposited onto a substrate to form a microarray which was further
modiﬁed using copper ions and capture proteins. When the analyte of
interest interacts with the capture protein the distance from the copper
ion to the SWNT is changed, leading to a change in the dielectric
environment and a shift in the nanotube ﬂuorescence.90 This new
platform has potential for both antibody and protein sensing applications in the future.
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Figure 4. Illustration of the proposed mechanism of the difference in nanotube emission response upon interaction with alkylating agents. (a) Cisplatin and
transplatin react with DNA on the nanotube to produce red shifts. (b) When an amphiphile, sodium dodecylbenzenesulfonate (SDBS), is introduced to the
system, large blue shifts in the ﬂuorescence take place mediated by the alkylating agents. (ﬁgure reproduced with permission from 87, © 2017 American
Chemical Society).

In vitro.—In vitro applications of SWNT biosensors have seen
recent advances in both intracellular and extracellular
applications.91–94 The next section highlights the recent advances
in SWNT sensor research with cell culture.
Delivery of the newly designed SWNT sensors to biological
samples continues to be an obstacle in the use of SWNT for
biomedical research. One step towards the use of SWNT sensors
with biological samples was Kruss et al.’s study detecting dopamine
in real time as it was released from neuroprogenitor cells.91 Kruss
et al.’s study showed a high spatial and temporal resolution of
dopamine released from cells (shown in Fig. 5) and improved the
ability to investigate small changes in analyte concentration in
vitro.91 Along the same lines, Dinarvand et al. used a SWNT
aptamer sensor to detect serotonin release from cells with both
spatial and temporal speciﬁcity.92 The sensors along the perimeter of
the cells allowed for many sites of quantiﬁcation and could lead to
important discoveries in cell to cell signaling.92 Extracellular protein

detection has also seen recent progress with Chio et al.’s 2019 paper,
in which peptoid-SWNT assemblies detected lectin protein wheat
germ agglutinin in cell culture conditions.93 The peptoid wrapping
was shown to interact with the proteins of interest while the proteins
were able to retain function following the interaction.93 This work
paves the way for extracellular detection of complex analytes.
Intracellular detection of analytes by SWNT based optical probes
has been hindered by a lack of mechanisms for targeted aggregation
of sensors to speciﬁc proteins or organelles. Recently, BudhathokiUprety et al. showed that guanidinium-functionalized helical polycarbodiimide SWNT entery into HeLa cell nuclei was mediated by
the import receptor importin β.94 The nanotube photoluminescence
exhibited distinct red-shifting upon entry to the nucleus, making the
sensors a reporter of the importin β-mediated nuclear transport
process.94 This research also shows the potential of using SWNT’s
own properties to determine the location of the nanoparticles within
cells.
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Figure 5. Nanosensor array that allows for real time detection of analyte released from cells91 (a) brightﬁeld image of cell, (b) heatmap showing analyte
concentration before cell stimulation, (c) analyte concentration at stimulation point, and (d) analyte concentration 4 s post stimulation (ﬁgure reprinted with
permission from 91).

Ex vixo.—Ex vivo detection of biomarkers in biological media
(serum, blood, urine, etc) has experienced sensor library expansion,
a new immobilization scheme, and improved disease state
detection.95–99
The development of each SWNT sensor is time intensive, and
therefore the library of SWNT sensors is limited. Despite this
difﬁculty, multiple new SWNT sensors have been developed over
the past few years for use with biological media.95–99 Bisker et al.
developed an insulin sensor by wrapping 10,6 SWNT with
C16-PEG-ceramide polymers.95 It was found that insulin does not
have an afﬁnity to C16-PEG-ceramide when it is not attached to
nanotubes, but rather insulin interacts with C16-PEG-ceramide only
when it is wrapped around the nanotube. These results suggest that
the sensor’s response to insulin is due to molecular recognition
rather than a measurement of other physical parameters.95 The
C16-PEG-ceramide wrapped SWNT responded to the presence of
insulin in both solution and serum through ﬂuorescence quenching.95
Another protein, RAP1, was detected using aptamers anchored to
SWNT by ss(AT)11, demonstrating an ability to create SWNT
sensors with already existing aptamer technology.96 The

(AT)11-RAP1-SWNT sensor responds to the presence of RAP1
with a concentration dependent increase in ﬂuorescence intensity,
allowing for single molecule detection of the protein in serum.96
A sensor that functions in urine, detecting microalbuminuria, a
marker for cardiovascular disease, cancer, metabolic disease, diabetes, hypertension, and atherosclerosis was developed by
Budhathoki-Uprety et al. in 2019.97 Carboxy-polycarbodiimide
(PCD) wrapped 9,4 SWNT shows a concentration dependent signal
change in response to the presence of microalbuminuria and
incorporation into a nanosensor paint allows for portability of a
nanosensor array.97 The use of the carboxy-PCD-SWNT complexes
in urine expands the use of SWNT sensors into human samples and
the development of a nanosensor paint allows for readings outside of
laboratory settings.
Detection of disease speciﬁc markers or direct virus detection has
also been shown in biological media in recent years.98,99 Williams
et al. developed a SWNT sensor for a metastatic prostate cancer
marker, speciﬁcally urokinase plasminogen activator (uPA), in
human blood products (see Fig. 6).98 SWNT was suspended with
anti-uPA antibody modiﬁed ssDNA to produce SWNT sensors that

Figure 6. Sensor detection of uPA in human blood products. (A) Addition of 100 nm uPA (ovarian cancer biomarker) to SWNT suspended in bovine serum,
human serum, and human plasma all show a distinct red shift in nanotube ﬂuorescence with no solution showing a signiﬁcantly different shift, indicating
consistent detection in various biological media. (B) Red shift of nanotube ﬂuorescence following addition of 100 nm uPA in human serum and human plasma
normalized to serum and plasma with no uPA addition, showing a plateu in ﬂuorescence shifting around 90 min (ﬁgure reproduced with permission from 98,
© 2018 American Chemical Society).
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Figure 7. (a) Single walled carbon nanotubes (SWNTs) embedded in Matrigel was imaged in vivo, with the excitation and emission signals located on opposite
sides of the mouse (ﬁgure reprinted with permission from 100, © 2017 American Chemical Society).

demonstrate a concentration dependent red shift of the ﬂuorescence
when exposed to uPA.98 The red shift response of these sensors was
observed in bovine serum, human serum, and human plasma with no
signiﬁcant difference in the response of the sensors to the
biomarker.98 Along the same lines, an HIV detecting SWNT sensor
was developed by Harvey et al. using denatured proteins to modulate
nanotube response in serum.99 A ssDNA-based wrapping was used
to make the nanotubes speciﬁc for intact virus RNA, and it was
discovered that denatured proteins help modulate the blue wavelength shift of the sensors due to HIV by interacting with exposed
hydrophobic sections along the nanotube.99
In vivo.—Advancements with in vivo applications include
improved tissue penetration depth, new and improved sensor
delivery platforms and increase in the types of analytes that can be
detected by SWNT.100–107
A major obstacle for SWNT sensors that has been improving
over the past three years is detection depth.100,101 In 2017, Lin et al.
functionalized and immobilized SWNT into Matrigel prior to
implantation in the mouse ovaries and collection of nIR ﬂuorescence, X-ray and CT data.100 Spectral triangulation was performed
on live mice by using an LED matrix of visible light to excite the
SWNT on one side of the animal and a grid of near infrared emission
collectors to acquire the signal on the opposing side of the mouse
(see Fig. 7).100 At each position on the emission collection grid,
ﬂuorescence intensity was measured through two alternating nIR-II
spectral ﬁlters, corresponding to weak and strong optical absorption
by water in tissues, with a photon counting InGaAs avalanche
photodiode. The ratio of the two nIR-II spectral intensities was used

to deduce the mass and location of the implanted SWNT. Using this
method, Lin et al. has been able to achieve imaging depths of 3.1
mm in vivo and over 10 mm in a tissue phantom despite the small
concentration of SWNT used (120 pg in vivo).100 Bonis‐O’Donnell
et al. has also increased tissue penetration depth of SWNT sensors
by decreasing signal scattering through the use of two-photon
excitation on brain tissue phantoms.101 HiPco nanotubes were
suspended with ss(GT)15 to create dopamine sensors, which were
then loaded into capillary tubes and placed 2 mm deep into brain
tissue phantoms.101 Excitation of the sensors was performed using a
two-photon 1560 nm excitation source and showed only a 4%
scattering of sensor emission through the tissue mimic, demonstrating the ability of two-photon excitation as a potential deep tissue
optical detection method for SWNT sensors.101
Sensor delivery plaforms have been another major obstacle in the
use of SWNT sensors in vivo. Previous attempts to localize SWNT
sensors in hydrogels have resulted in sensor response delays.85 To
address this issue, Hofferber et al. developed two novel hydrogel
systems for the localization and real-time detection of biological
analytes in vivo (shown in Fig. 8).102 SWNT sensors for nitric oxide
were either encapsulated within a liquid core of a 3D printed
hyaluronic acid hydrogel or used to decorate the surface of alginate
hydrogels.102 Both hydrogel-SWNT platforms localized sensors,
retained speciﬁcity, and maintained function for two months.
When the hydrogels were exposed to nitric oxide, SWNT sensors
responded in real time with ﬂuorescence quenching.102 Using a
different hydrogel platform, Lee et al. demonstrated the ﬁrst
placement of SWNT sensor implants into large animals, including
bony ﬁsh, sharks, eels, and turtles.103 The SWNT sensors were

Figure 8. Two hydrogels for in vivo delivery of single walled carbon nanotube (SWNT) sensors that react in real time. (a) 3D printed liquid-core hyaluronic acid
hydrogels and (b) alginate hydrogels decorated with SWNT sensors (ﬁgure reprinted with permission from 102, © 2019 WILEY-VCH Verlag GmbH & Co.
KGaA, Weinheim).

Journal of The Electrochemical Society, 2020 167 037530
detected at depths of up to 7 mm post sacriﬁce. Unfortunately,
detection of the SWNT signal in live animals was unsuccessful due
to animal movement, dispersion of the excitation source, and the
long exposure times required by the detector.103 Despite its inability
to detect the sensors in the live animals, this study took the ﬁrst step
in use of SWNT sensors in large animal models.
In vivo detection of various analytes with SWNT sensors has
been accomplished in smaller animal models. A sensor for the
detection of lipid accumulation in the endolysosomal lumen of mice
was developed by Galassi et al.104 A ssCTTC3TTC wrapped 9,4
SWNT acts as a sensor capable of detecting various lipid species,
including cholesterol, sphingomyelin, and oxidized low-density
lipoproteins (LDL).104 The ssCTTC3TTC 9,4 sensors showed
in vivo lipid detection and biocompatibility.104 A sensor for the
in vivo detection of ovarian cancer biomarker human epididymis
protein 4 (HE4) was developed by Williams et al.105 The biomarker
was shown to be speciﬁcally detected by ss(TAT)6-anchored goat
polyclonal anti-HE4 immunoglobulin G (IgG) antibody wrapped 9,4
SWNT, relying on a shift in ﬂuorescence wavelength for signal
quantiﬁcation.105 By wrapping 9,4 SWNT with ss(TAT)6-IgG antibody there is a constant ﬂuorescence intensity that has a concentration dependent blue-shift in response to the presence of HE4.105 The
subcutaneously implanted ss(TAT)6-IgG antibody SWNT was able
to demonstrate ovarian cancer biomarker HE4 detection in live
mice.105 Another mouse model by Harvey et al. detected doxorubicin with both subcutaneous and intraperitoneal sensor
platforms.106 DNA suspended nanotubes were found to have a
concentration dependent red shift in response to doxorubicin,
allowing nondestructive detection of doxorubicin in vivo for the ﬁrst
time.106 Another exciting breakthrough was performed by Mann
et al. when they conjugated SWNT sensors for dopamine to a GFP
binding nanobody and introduced the sensors to developing drosophila embryos.107 The motor protein kinesin-5 was labeled with GFP
and aggregation of nanobody-SWNT complexes on the protein was
seen upon injection.107 In this study, the SWNT sensors also
remained sensitive to dopamine, showing protein-targeted delivery
of a SWNT sensor in vivo.107
Conclusions
Single walled carbon nanotubes are small molecules with
extraordinary properties, which allows for the development of
biosensors for a variety of analytes. The high spatial and temporal
resolution of nIR ﬂuorescence in biological samples coupled with
the photostability of SWNT has allowed researchers to detect and
quantify biomarkers for a number of disease states and many more
analytes from biological processes. The ﬁeld of SWNT as optical
biosensors has continued to grow year after year and the library of
sensors is rapidly expanding, along with detection methods that are
allowing for higher resolution imaging and deeper tissue penetration.
There are many hurdles that still need to be overcome before this
class of optical biosensors can be used in a clinical setting, including
the stigma surrounding their biocompatibility. Early toxicology
reports comparing SWNT to asbestos has caused many scientists
outside the of the carbon nanotube ﬁeld to be wary of using nanotube
sensors in vivo, but with further characterization of SWNT
distribution in vivo, continued improvements in SWNT quantum
yield, and improved SWNT sensor delivery platforms the possibility
of using SWNT sensors in a clinical setting could become a reality.
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